Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Abstract Title Submitted by Hollie Pegram to the 2012 ASH Annual Meeting: Expansion and Modification of Umbilical Cord Blood T Cells with a Chimeric Antigen Receptor and IL-12

Hollie J. Pegram, PhD, Juliet Barker, MBBS, Sergio Giralt, MD, Renier J Brentjens, MD, PhD

Blood (2012) 120 (21): 1907.

https://doi.org/10.1182/blood.V120.21.1907.1907

Published: 2012

Journal Articles

Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning

Hollie J. Pegram, James C. Lee, Erik G. Hayman, Gavin H. Imperato, Thomas F. Tedder, Michel Sadelain, Renier J. Brentjens

Blood (2012) 119 (18): 4133–4141.

https://doi.org/10.1182/blood-2011-12-400044

Published: 2012

Includes: Supplemental data

Journal Articles

Tumor Specific T Cells Modified to Secrete IL-12 Eradicate Systemic Tumors in the Absence of Prior Toxic Chemotherapy Conditioning Regimens

Hollie J. Pegram, PhD, James Lee, MD, Erik Hayman, BS, Gavin H Imperato, Thomas J. Tedder, PhD, Renier J Brentjens, MD, PhD

Blood (2011) 118 (21): 3120.

https://doi.org/10.1182/blood.V118.21.3120.3120

Published: 2011

Journal Articles

Adoptive Therapy with Human CD19 (hCD19)-Targeted T Cells Further Modified to Express IL-12 Overcome the Need for Prior Lymphodepletion to Eradicate Established hCD19 + Tumors and Induce B Cell Aplasias In Immune Competent hCD19 + Transgenic Mice

Erik Hayman, BS, James Lee, MD, Hollie J. Pegram, PhD, Renier Brentjens, MD, PhD

Blood (2010) 116 (21): 2097.

https://doi.org/10.1182/blood.V116.21.2097.2097

Published: 2010

Journal Articles

CD19 Targeted Cord Blood Derived T Cells for Cancer Immunotherapy.

Hollie J. Pegram, PhD, Vincent LaRussa, PhD, Renier Brentjens, MD, PhD

Blood (2010) 116 (21): 3767.

https://doi.org/10.1182/blood.V116.21.3767.3767

Published: 2010

NARROW

Abstract Title Submitted by Hollie Pegram to the 2012 ASH Annual Meeting: Expansion and Modification of Umbilical Cord Blood T Cells with a Chimeric Antigen Receptor and IL-12

Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning

Tumor Specific T Cells Modified to Secrete IL-12 Eradicate Systemic Tumors in the Absence of Prior Toxic Chemotherapy Conditioning Regimens

Adoptive Therapy with Human CD19 (hCD19)-Targeted T Cells Further Modified to Express IL-12 Overcome the Need for Prior Lymphodepletion to Eradicate Established hCD19 + Tumors and Induce B Cell Aplasias In Immune Competent hCD19 + Transgenic Mice

CD19 Targeted Cord Blood Derived T Cells for Cancer Immunotherapy.

Email alerts

ASH Publications

American Society of Hematology

Abstract Title Submitted by Hollie Pegram to the 2012 ASH Annual Meeting: Expansion and Modification of Umbilical Cord Blood T Cells with a Chimeric Antigen Receptor and IL-12

Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning

Tumor Specific T Cells Modified to Secrete IL-12 Eradicate Systemic Tumors in the Absence of Prior Toxic Chemotherapy Conditioning Regimens

Adoptive Therapy with Human CD19 (hCD19)-Targeted T Cells Further Modified to Express IL-12 Overcome the Need for Prior Lymphodepletion to Eradicate Established hCD19 + Tumors and Induce B Cell Aplasias In Immune Competent hCD19 + Transgenic Mice

CD19 Targeted Cord Blood Derived T Cells for Cancer Immunotherapy.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only